Abstract | BACKGROUND: The opioid system is considered a potential therapeutic target in a variety of neurological disorders. Delta opioid receptors (DORs) are broadly expressed in the brain, and their activation protects cells from hypoxic/ischemic insults by counteracting disruptions of ionic homeostasis and initiating neuroprotective pathways. The DOR agonist D-Ala2-D-Leu2-Enkephalin ( DADLE) promotes neuronal survival, mitigates apoptotic pathways, and protects neurons and glial cells from ischemia-induced cell death, thus making DADLE a promising therapeutic option for stroke. The significant amount of research regarding DORs and DADLE in the last decades also suggests their potential in treating other neurological disorders. METHODS: This review compiled relevant literature detailing the role of DORs and agonists in central nervous system function and neuropathologies. RESULTS: Several studies demonstrate potential mechanisms implicating a key interaction between DORs and DADLE in conferring neuroprotective benefits. A better understanding of DOR function in disease-specific contexts is critical to transitioning DOR agonists into the clinic as a therapy for stroke and other neurological diseases. CONCLUSION: Evidence-based studies support the potential of the delta- opioid family of receptors and its ligands in developing novel therapeutic strategies for stroke and other brain disorders.
|
Authors | Jea-Young Lee, M Grant Liska, Marci Crowley, Kaya Xu, Sandra A Acosta, Cesar V Borlongan, Vivian A Guedes |
Journal | Current drug discovery technologies
(Curr Drug Discov Technol)
Vol. 15
Issue 2
Pg. 94-108
( 2018)
ISSN: 1875-6220 [Electronic] United Arab Emirates |
PMID | 29032758
(Publication Type: Journal Article, Review)
|
Copyright | Copyright© Bentham Science Publishers; For any queries, please email at [email protected]. |
Chemical References |
- Analgesics, Opioid
- Receptors, Opioid, delta
- Enkephalin, Leucine-2-Alanine
|
Topics |
- Analgesics, Opioid
(metabolism, pharmacology, therapeutic use)
- Animals
- Enkephalin, Leucine-2-Alanine
(metabolism, pharmacology, therapeutic use)
- Humans
- Nervous System Diseases
(drug therapy, metabolism)
- Receptors, Opioid, delta
(agonists, metabolism)
|